These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2084960)

  • 21. Prevalence of hypertension and its complications in congenital prekallikrein deficiency: analysis of all reported cases and clinical significance.
    Girolami A; Ferrari S; Cosi E; Sambado L; Girolami B
    Blood Coagul Fibrinolysis; 2015 Jul; 26(5):560-3. PubMed ID: 25886833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factor XII-induced fibrinolysis. Diminished proactivator activity and drastic reduction of activator activity in Fletcher factor-deficient plasma gamma globulin.
    Espana F; Aznar J; Estelles A
    J Lab Clin Med; 1982 Nov; 100(5):756-70. PubMed ID: 6182261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The phenotype of newly diagnosed Graves' disease in Italy in recent years is milder than in the past: results of a large observational longitudinal study.
    Bartalena L; Masiello E; Magri F; Veronesi G; Bianconi E; Zerbini F; Gaiti M; Spreafico E; Gallo D; Premoli P; Piantanida E; Tanda ML; Ferrario M; Vitti P; Chiovato L
    J Endocrinol Invest; 2016 Dec; 39(12):1445-1451. PubMed ID: 27465670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thrombotic events in patients with congenital prekallikrein deficiency: a critical evaluation of all reported cases.
    Girolami A; Allemand E; Bertozzi I; Candeo N; Marun S; Girolami B
    Acta Haematol; 2010; 123(4):210-4. PubMed ID: 20424433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The epidemiology of Graves' disease: evidence of a genetic and an environmental contribution.
    Hemminki K; Li X; Sundquist J; Sundquist K
    J Autoimmun; 2010 May; 34(3):J307-13. PubMed ID: 20056533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prekallikrein deficiency in a family of Belgian horses.
    Geor RJ; Jackson ML; Lewis KD; Fretz PB
    J Am Vet Med Assoc; 1990 Sep; 197(6):741-5. PubMed ID: 2211324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Severe prekallikrein deficiency due to a compound heterozygosis in the KLKB1-gene].
    Maak B; Kochhan L; Heuchel P; Jenderny J
    Hamostaseologie; 2009 May; 29(2):187-9. PubMed ID: 19404525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prekallikrein, HMW-kininogen and factor XII in various disease states.
    Deutsch E; Dragosics B; Kopsa H; Mannhalter C; Rainer H
    Thromb Res; 1983 Jul; 31(2):351-64. PubMed ID: 6356459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fletcher factor deficiency and myocardial infarction.
    Currimbhoy Z; Vinciguerra V; Palakavongs P; Kuslansky P; Degnan TJ
    Am J Clin Pathol; 1976 Jun; 65(6):970-4. PubMed ID: 937251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Severe prekallikrein deficiencies due to homozygous C529Y mutations.
    François D; Trigui N; Leterreux G; Flaujac C; Horellou MH; Mazaux L; Vignon D; Conard J; de Mazancourt P
    Blood Coagul Fibrinolysis; 2007 Apr; 18(3):283-6. PubMed ID: 17413767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prekallikrein (Fletcher Factor) Deficiency and Prolongation of APTT Reaction].
    Dietzel H; Lutze G; Kätzel R; Liebscher K
    Med Klin (Munich); 2003 Oct; 98(10):587-90. PubMed ID: 14586514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma levels of factor XII, prekallikrein and high molecular weight kininogen in normal blood donors and patients having suffered venous thrombosis.
    Gallimore MJ; Harris SL; Jones DW; Winter M
    Thromb Res; 2004; 114(2):91-6. PubMed ID: 15306150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma prekallikrein (Fletcher factor) deficiency in a patient with chronic lymphocytic leukemia.
    Waddell CC; Brown JA; Udden MM
    South Med J; 1980 Dec; 73(12):1653-5. PubMed ID: 6905267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanized assay of plasma prekallikrein by activation with Pseudomonas aeruginosa elastase and amidolysis of chromogenic substrate.
    Shibuya Y; Yamamoto T; Tanaka H; Semba U; Kambara T; Okabe H
    Clin Chim Acta; 1991 Aug; 200(2-3):119-27. PubMed ID: 1777962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prekallikrein deficiency in man.
    Wuepper KD
    J Exp Med; 1973 Dec; 138(6):1345-55. PubMed ID: 4762550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Limited genetic susceptibility to severe Graves' ophthalmopathy: no role for CTLA-4 but evidence for an environmental etiology.
    Villanueva R; Inzerillo AM; Tomer Y; Barbesino G; Meltzer M; Concepcion ES; Greenberg DA; MacLaren N; Sun ZS; Zhang DM; Tucci S; Davies TF
    Thyroid; 2000 Sep; 10(9):791-8. PubMed ID: 11041456
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Severe prekallikrein deficiency associated with homozygosity for an Arg94Stop nonsense mutation.
    Wynne Jones D; Russell G; Allford SL; Burdon K; Hawkins GA; Bowden DW; Minaee S; Mumford AD
    Br J Haematol; 2004 Oct; 127(2):220-3. PubMed ID: 15461630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prekallikrein deficiency (Fletcher trait)].
    Isobe J
    Ryoikibetsu Shokogun Shirizu; 1998; (21 Pt 2):468-70. PubMed ID: 9833544
    [No Abstract]   [Full Text] [Related]  

  • 39. Prevalence of Cardiovascular Disorders in African-Americans With Congenital Prekallikrein Deficiency Versus Caucasians-Americans With the Same Defect.
    Girolami A; Ferrari S; Girolami B
    Clin Appl Thromb Hemost; 2020; 26():1076029620972481. PubMed ID: 33176434
    [No Abstract]   [Full Text] [Related]  

  • 40. Function and immunochemistry of prekallikrein-high molecular weight kininogen complex in plasma.
    Scott CF; Colman RW
    J Clin Invest; 1980 Feb; 65(2):413-21. PubMed ID: 7356688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.